ARCK Stock Ownership Activity

ARBOR RAPHA CAPITAL BIOHOLDI 13F holders

No value investing guru has made any change to the ARBOR RAPHA CAPITAL BIOHOLDI (ARCK) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying ARCK now?

According to the latest SEC filing(s) ARBOR RAPHA CAPITAL BIOHOLDI (ARCK) has not been purchased by any super investor.

To see more about who is investing in ARBOR RAPHA CAPITAL BIOHOLDI (ARCK), please go to the ARCK ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2022 Q4 (1 result)
Howard Marks
Oaktree Capital Management
-100.00%
-64,500
-0.01%
0.00%
Current price: $11.90 17.59% Reported price*: $10.12
2021 Q4 (1 result)
Howard Marks
Oaktree Capital Management
buy
+100,000
+0.01%
0.01%
Current price: $11.90 19.60% Reported price*: $9.95
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.